Glader B - Search Results

1

Allen GA, Glader B. Allen GA, et al. Among authors: glader b. Pediatr Clin North Am. 2002 Dec;49(6):1239-56. doi: 10.1016/s0031-3955(02)00091-3. Pediatr Clin North Am. 2002. PMID: 12580364 Review.

2

Bleeding symptoms and laboratory correlation in patients with severe von Willebrand disease.

Metjian AD, Wang C, Sood SL, Cuker A, Peterson SM, Soucie JM, Konkle BA; HTCN Study Investigators. Metjian AD, et al. Haemophilia. 2009 Jul;15(4):918-25. doi: 10.1111/j.1365-2516.2009.02025.x. Epub 2009 Apr 7. Haemophilia. 2009. PMID: 19473418

3

Care of the critically ill child: the bleeding neonate.

Glader BE, Buchanan GR. Glader BE, et al. Pediatrics. 1976 Oct;58(4):548-55. Pediatrics. 1976. PMID: 972796

4

Red Blood Cell Enzyme Disorders.

Grace RF, Glader B. Grace RF, et al. Among authors: glader b. Pediatr Clin North Am. 2018 Jun;65(3):579-595. doi: 10.1016/j.pcl.2018.02.005. Pediatr Clin North Am. 2018. PMID: 29803284 Review.

5

Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.

Key NS, Aledort LM, Beardsley D, Cooper HA, Davignon G, Ewenstein BM, Gilchrist GS, Gill JC, Glader B, Hoots WK, Kisker CT, Lusher JM, Rosenfield CG, Shapiro AD, Smith H, Taft E. Key NS, et al. Among authors: glader b. Thromb Haemost. 1998 Dec;80(6):912-8. Thromb Haemost. 1998. PMID: 9869160 Clinical Trial.

6

Updated analysis: central venous access device infection rates in an expanded cohort of paediatric patients with severe haemophilia receiving prophylactic recombinant tissue plasminogen activator.

McCarthy CE, O'Brien M, Andrews J, Zoland JM, Macasiray E, Wong W, Lo C, Glader B, Tamaresis J, Jeng M. McCarthy CE, et al. Among authors: glader b. Haemophilia. 2016 Jan;22(1):81-6. doi: 10.1111/hae.12772. Epub 2015 Aug 7. Haemophilia. 2016. PMID: 26248602

7

Monthly recombinant tissue plasminogen activator administration to implantable central venous access devices decreases infections in children with haemophilia.

Jeng MR, O'Brien M, Wong W, Zoland J, Lea J, Tang N, Glader B. Jeng MR, et al. Among authors: glader b. Haemophilia. 2009 Nov;15(6):1272-80. doi: 10.1111/j.1365-2516.2009.02063.x. Epub 2009 Jul 10. Haemophilia. 2009. PMID: 19601989

8

Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIII.

Addiego J, Kasper C, Abildgaard C, Hilgartner M, Lusher J, Glader B, Aledort L. Addiego J, et al. Among authors: glader b. Lancet. 1993 Aug 21;342(8869):462-4. doi: 10.1016/0140-6736(93)91593-b. Lancet. 1993. PMID: 8102429

9

Leukocyte counts in children with sickle cell disease. Comparative values in the steady state, vaso-occlusive crisis, and bacterial infection.

Buchanan GR, Glader BE. Buchanan GR, et al. Among authors: glader be. Am J Dis Child. 1978 Apr;132(4):396-8. doi: 10.1001/archpedi.1978.02120290068013. Am J Dis Child. 1978. PMID: 645659

10

Benign course of extreme hyperbilirubinemia in sickle cell anemia: analysis of six cases.

Buchanan GR, Glader BE. Buchanan GR, et al. Among authors: glader be. J Pediatr. 1977 Jul;91(1):21-4. doi: 10.1016/s0022-3476(77)80436-8. J Pediatr. 1977. PMID: 874660

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

148 results

Search Page